eravac
laboratorios hipra, s.a. - inactivated rabbit haemorrhagic disease type 2 virus (rhdv2), strainv-1037 - inaktivierte virale impfstoffe - kaninchen - für die aktive immunisierung von kaninchen ab einem alter von 30 tagen zu reduzieren sterblichkeit durch die kaninchen hämorrhagische krankheit typ-2-virus (rhdv2).
fatrovax rhd
fatro s.p.a - rabbit hemorrhagic disease virus 2 vp1ab, rabbit hemorrhagic disease virus vp1a - immunologischen arzneimitteln für leporidae - kaninchen - for active immunisation of rabbits from the age of 28 days to reduce mortality, infection, clinical signs and organ lesions of rabbit haemorrhagic disease caused by rhdv1 and rhdv2.
filavac vhd k c+v
filavie s.a.s. (4609005) - rabbit haemorrhagic disease-virus, stamm lp.sv.2012 (varianzstamm 2010, rhdv2), inaktiviert; rabbit haemorrhagic disease-virus, stamm im507.sc.2011 (klassischer stamm, rhdv1), inaktiviert - injektionssuspension - rabbit haemorrhagic disease-virus, stamm lp.sv.2012 (varianzstamm 2010, rhdv2), inaktiviert (38642) 1 protektive dosis 90%; rabbit haemorrhagic disease-virus, stamm im507.sc.2011 (klassischer stamm, rhdv1), inaktiviert (38643) 1 protektive dosis 90% - kaninchen
filavac vhd k c+v ad us. vet. injektionssuspension für kaninchen
provet ag - rabbit haemorrhagic disease virus (rhdv1), classical strain (im 507.sc.2011), inactivated, rabbit haemorrhagic disease virus (rhdv2), variant strain (lp.sv.2012), inactivated - injektionssuspension für kaninchen - rabbit haemorrhagic disease virus (rhdv1), classical strain (im 507.sc.2011), inactivated ≥ 1.0 u., rabbit haemorrhagic disease virus (rhdv2), variant strain (lp.sv.2012), inactivated ≥ 1.0 u., aluminii oxidum hydricum 0.35 mg, e 223, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, natrii hydroxidum, aqua ad iniectabile, ad suspensionem pro dosi 0.5 ml. - inaktivierter impfstoff gegen das rabbit haemorrhagic disease virus bei kaninchen - impfstoffe
covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - impfstoffe - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - influenza-virus-oberflächenantigene (hämagglutinin und neuraminidase) des stammes a / vietnam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - impfstoffe - aktive immunisierung gegen den h5n1-subtyp des influenza a-virus. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
filavac vhd k c+v injektionssuspension
filavie - rhd-virus, inaktiviert - injektionssuspension - rhd-virus, inaktiviert - rabbit haemorrhagic disease virus - kaninchen
btvpur btv 4 ad us. vet. suspension injectable pour ovins et bovins
biokema s.a. - inactivated bluetongue virus, serotype 4 - suspension injectable pour ovins et bovins - inactivated bluetongue virus, serotype 4 1.86 log10 u., aluminii oxidum hydricum 2.7 mg, saponinum 30 u., ad suspensionem pro dosi 1 ml. - vaccin inactivé contre l’orbivirus bovin (maladie de la langue bleue) chez les bovins et ovins - impfstoffe
zulvac 1+8 ovis
zoetis belgium sa - inactivated bluetongue virus, serotype 1, strain btv-1/alg2006/01, inactivated bluetongue virus, serotype 8, strain btv-8/bel2006/02 - bluetongue virus, sheep, inactivated viral vaccines - schaf - aktive immunisierung von schafen von 1. 5 monate alt, um einer virämie vorzubeugen, die durch das blauzungenvirus, serotypen 1 und 8, verursacht wird. beginn der immunität: 21 tage nach abschluss der grundimmunisierung. dauer der immunität: 12 monate.
bovalto respi 3 injektionssuspension
boehringer ingelheim animal health belgium - bovine respiratory-synctial-virus (brsv); parainfluenza-3-virus; mannheimia haemolytica, inactivated - injektionssuspension - bovine respiratory-synctial-virus (brsv) ; parainfluenza-3-virus ; mannheimia haemolytica, inactivated - inactivated viral and inactivated bacterial vaccines - rind